Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics

Oncogene
Dan C McManusE C LaCasse

Abstract

Stable expression of short-hairpin RNAs (shRNAs) directed against the X-linked inhibitor of apoptosis (XIAP) resulted in the generation of three MDA-MB-231 cell lines (XIAP shRNA cells) with reductions in XIAP mRNA and protein levels > 85% relative to MDA-MB-231 cells stably transfected with the U6 RNA polymerase III promoter alone (U6 cells). This RNA interference (RNAi) approach dramatically sensitized these cells to killing by the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Importantly, loss of XIAP also sensitized the cells to killing by taxanes but had no additional effects on killing by carboplatin and doxorubicin. The increased sensitivity of the XIAP shRNA cells to killing by TRAIL and taxanes correlated with enhanced caspase cleavage and activation, including caspase-8, and robust processing of poly(ADP-ribose) polymerase and BID compared to U6 cells. Additionally, increasing XIAP levels by adenovirus-mediated expression protected both XIAP shRNA and U6 cells from TRAIL killing in a dose-dependent manner. The effects observed by stable RNAi with respect to TRAIL sensitization were also achieved following downregulation of XIAP in Panc-1 cells treated with a second-generation, mixed-backbone antisen...Continue Reading

References

Jun 21, 1985·Science·Y TsujimotoC M Croce
Jun 1, 1985·Applied Biochemistry and Biotechnology·R J Linhardt
Oct 18, 1996·Cell·E S AlnemriJ Yuan
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·S AgrawalR Zhang
Apr 10, 1997·Experimental Cell Research·C K HsuJ A Fontana
Jul 17, 1997·Nature·Q L DeverauxJ C Reed
Aug 1, 1997·Nature Medicine·G AmbrosiniD C Altieri
Apr 16, 1998·The Journal of Clinical Investigation·M OharaR W Schrier
May 9, 1998·The Journal of Biological Chemistry·R TakahashiJ C Reed
Jan 23, 1999·Oncogene·E C LaCasseA E MacKenzie
Mar 21, 2001·Cell·J ChaiP Dataa
Mar 21, 2001·Cell·S J RiedlG S Salvesen
Jul 4, 2001·Nature Reviews. Molecular Cell Biology·M Holcik, R G Korneluk
Sep 5, 2002·Nature Reviews. Cancer·Suzanne Cory, Jerry M Adams
Feb 1, 2003·Cancer Cell·John C Reed
Jun 5, 2003·Nature Reviews. Molecular Cell Biology·Derek M DykxhoornPhillip A Sharp
Jul 17, 2003·The Journal of Biological Chemistry·Ramesh HegdeEmad S Alnemri
Nov 25, 2003·Oncogene·Peter ListonRobert G Korneluk
Jan 1, 1997·Apoptosis : an International Journal on Programmed Cell Death·P ListonR G Korneluk
Feb 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Salah M AouadRafick-Pierre Sekaly
Mar 19, 2004·The Journal of Pharmacology and Experimental Therapeutics·Brian S CummingsRick G Schnellmann

❮ Previous
Next ❯

Citations

Sep 12, 2006·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Huihua XiongLiang Zhuang
Nov 12, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Simone MocellinDonato Nitti
May 25, 2007·Cancer Chemotherapy and Pharmacology·Gavin J GordonRaphael Bueno
Nov 27, 2008·Cancer Chemotherapy and Pharmacology·Kate ConnollySylvie Guichard
Jun 7, 2013·Journal of Bone and Mineral Metabolism·Chang Yang, Deborah Veis Novack
Jul 6, 2006·Apoptosis : an International Journal on Programmed Cell Death·Bert SchutteFrans C S Ramaekers
Apr 19, 2007·Apoptosis : an International Journal on Programmed Cell Death·Mara S LippaPamela M Holland
Jun 19, 2007·Apoptosis : an International Journal on Programmed Cell Death·Allison M HunterRobert G Korneluk
Oct 30, 2008·Journal of Medicinal Chemistry·Jui-Wen HuangMaurizio Pellecchia
Feb 9, 2008·Cell Death and Differentiation·C HwangC S Duckett
Feb 19, 2011·Cell Death and Differentiation·M DardingP Meier
Apr 25, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Maoxin WuDavid E Burstein
Jul 24, 2010·Nature Reviews. Cancer·Mads Gyrd-Hansen, Pascal Meier
Feb 2, 2012·Nature Reviews. Drug Discovery·Simone Fulda, Domagoj Vucic
Oct 22, 2008·Oncogene·E C LaCasseR G Korneluk
Oct 18, 2012·Neuro-oncology·Jee Suk LeeYoung Hyun Yoo
Jan 23, 2013·The Cancer Journal·Robert R ZielinskiKim N Chi
Feb 16, 2010·Molecular and Cellular Biology·Graham F BradyColin S Duckett
Oct 4, 2005·The Journal of Clinical Investigation·Casey W Wright, Colin S Duckett
Jul 1, 2009·Breast Cancer Research : BCR·Fiona M FosterCharles H Streuli
Sep 28, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Ute FischerKlaus Schulze-Osthoff
Dec 13, 2005·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Zhuo ZhangHui Wang
Nov 13, 2008·Haematologica·Grégoire DesplanquesSophie Barillé-Nion
Jun 28, 2012·World Journal of Gastroenterology : WJG·Chun JiangYi-Xiong Li
Apr 2, 2014·Journal of Medicinal Chemistry·Stephen M CondonSrinivas K Chunduru
Oct 14, 2011·Future Oncology·Ronit Elhasid, Sarit Larisch
Dec 22, 2012·Leukemia Research and Treatment·Gabriela Nestal de MoraesRaquel Ciuvalschi Maia
Dec 1, 2009·Journal of Cancer Research and Clinical Oncology·Shin-ichi WatanabeHideki Sakai
Jul 16, 2008·Expert Opinion on Therapeutic Targets·S M C LangemeijerJ H Jansen
Nov 22, 2007·Expert Opinion on Therapeutic Targets·Emma J DeanCaroline Dive
Sep 26, 2007·Expert Review of Anticancer Therapy·Simone Fulda
Apr 17, 2013·Expert Opinion on Investigational Drugs·Lakshmikanth KatragaddaGautam Borthakur
May 31, 2006·Expert Opinion on Investigational Drugs·Kathryn TaylorCaroline Dive
Feb 4, 2011·Cancer Treatment Reviews·P A ZucaliA Santoro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis